4.03 USD
↗ 0.10 (2.55%)LIVE (AS OF 03:03 PM EST)
Corbus Pharmaceuticals Holdings, Inc.
CRBPNASDAQ • USD
Market: OPEN
Shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) are trading at $4.03. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest CRBP is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 10, 2026.
Open?$4.04
High?$4.25
Low?$3.81
Prev. Close?$3.93
Volume?404.4K
Avg. Volume?1.1M
VWAP?$4.05
Rel. Volume?0.37x
Bid / Ask
Bid?$4.00 × 100
Ask?$4.02 × 100
Spread?$0.02
Midpoint?$4.01
Valuation & Ratios
Market Cap?81.0M
Shares Out?18.7M
Float?18.6M
Float %?96.3%
P/E Ratio?N/A
P/B Ratio?0.79
EPS?-$4.95
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Themes
Employees
36
Market Cap
81.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-10-24
Address
500 RIVER RIDGE DRIVE
NORWOOD, MA 02062
Phone: 617-963-0103
NORWOOD, MA 02062
Phone: 617-963-0103
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?41
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.62Distress
Confidence?54%Low
Short InterestHigh
Short % of Float?17.42%High
Short Interest?3.2M
Days to Cover?3.5
Free Float18.6M
Avg Daily Volume933.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?5.71Strong
Quick Ratio?5.71Strong
Cash Ratio?1.09Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.79CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-99.7%WEAK▾
S&P3
ROA?-80.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-86687000
Enterprise Value?$57.6M
Fundamentals ratios updated end of day